ATE13667T1 - 8-aza-16,16-difluor-prostanoide. - Google Patents
8-aza-16,16-difluor-prostanoide.Info
- Publication number
- ATE13667T1 ATE13667T1 AT81303641T AT81303641T ATE13667T1 AT E13667 T1 ATE13667 T1 AT E13667T1 AT 81303641 T AT81303641 T AT 81303641T AT 81303641 T AT81303641 T AT 81303641T AT E13667 T1 ATE13667 T1 AT E13667T1
- Authority
- AT
- Austria
- Prior art keywords
- aza
- difluoroprostanoids
- stereo
- active
- prostanoids
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 1
- 229940127293 prostanoid Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/176,784 US4320136A (en) | 1980-08-11 | 1980-08-11 | 8-Aza-16,16-difluoroprostanoids |
| EP81303641A EP0046082B1 (de) | 1980-08-11 | 1981-08-10 | 8-Aza-16,16-difluor-prostanoide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE13667T1 true ATE13667T1 (de) | 1985-06-15 |
Family
ID=22645804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT81303641T ATE13667T1 (de) | 1980-08-11 | 1981-08-10 | 8-aza-16,16-difluor-prostanoide. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4320136A (de) |
| EP (1) | EP0046082B1 (de) |
| JP (1) | JPS5754166A (de) |
| AT (1) | ATE13667T1 (de) |
| CA (1) | CA1161447A (de) |
| DE (1) | DE3170838D1 (de) |
| DK (1) | DK352281A (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4530933A (en) * | 1982-12-27 | 1985-07-23 | E. I. Du Pont De Nemours And Company | 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents |
| US4456613A (en) * | 1982-12-27 | 1984-06-26 | E. I. Du Pont De Nemours And Company | 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof |
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| PT1339678E (pt) | 2000-11-27 | 2007-11-30 | Pfizer Prod Inc | Agonistas selectivos do receptor ep4 no tratamento de osteoporose |
| ES2254726T3 (es) | 2001-07-16 | 2006-06-16 | F. Hoffmann-La Roche Ag | Analogos de prostaglandina como agonistas receptores de ep4. |
| RU2296122C2 (ru) * | 2001-07-16 | 2007-03-27 | Ф.Хоффманн-Ля Рош Аг | Производные 2-пирролидона в качестве простаноидных агонистов и фармацевтическая композиция |
| NZ530885A (en) * | 2001-07-23 | 2007-09-28 | Ono Pharmaceutical Co | Remedies for diseases with bone mass loss having EP4 agonist as the active ingredient |
| US20040254230A1 (en) * | 2001-12-03 | 2004-12-16 | Ogidigben Miller J. | Method for treating ocular hypertension |
| RU2311409C2 (ru) * | 2003-01-10 | 2007-11-27 | Ф.Хоффманн-Ля Рош Аг | Производные 2-пиперидона в качестве агонистов простагландина |
| US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US20080058375A1 (en) * | 2004-01-08 | 2008-03-06 | Elworthy Todd R | 2-Piperidone derivatives as prostaglandin antagonists |
| CA2738045C (en) * | 2010-05-28 | 2019-02-19 | Simon Fraser University | Conjugate compounds, methods of making same, and uses thereof |
| CN107802623B (zh) | 2012-07-19 | 2020-10-30 | 开曼化学股份有限公司 | 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物 |
| EP3235817B1 (de) | 2013-03-15 | 2018-12-12 | Cayman Chemical Company, Incorporated | Lactamverbindungen als ep4-rezeptorselektive agonisten zur verwendung bei der behandlung von ep4-vermittelten erkrankungen und zuständen |
| WO2014144610A1 (en) | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
| JP6368351B2 (ja) | 2013-03-15 | 2018-08-01 | ケイマン ケミカル カンパニー， インコーポレーテッド | ジフルオロラクタムアナログを合成する方法 |
| JP2016527006A (ja) | 2013-07-19 | 2016-09-08 | ケイマン ケミカル カンパニー， インコーポレーテッド | 骨成長を促進するための方法、システム、及び組成物 |
| US9650414B1 (en) | 2014-05-30 | 2017-05-16 | Simon Fraser University | Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof |
| CN107849072B (zh) | 2015-06-12 | 2020-12-15 | 西蒙弗雷泽大学 | 酰胺连接的ep4激动剂-二膦酸盐化合物及其用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3873566A (en) * | 1973-02-28 | 1975-03-25 | Du Pont | 3-Pyrazolidinones and pyrazolidines |
| US3974190A (en) * | 1973-07-20 | 1976-08-10 | The Upjohn Company | 16-Fluoro prostaglandin A1 analogs |
| US3969376A (en) * | 1973-07-20 | 1976-07-13 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin E1 analogs |
| US3974189A (en) * | 1973-07-20 | 1976-08-10 | The Upjohn Company | 16-Fluoro prostaglandin E2 analogs |
| US3962293A (en) * | 1973-07-20 | 1976-06-08 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin F1 |
| US3974192A (en) * | 1973-07-20 | 1976-08-10 | The Upjohn Company | 16-Fluoro prostaglandin B1 analogs |
| US3969378A (en) * | 1973-07-20 | 1976-07-13 | The Upjohn Company | 16-Fluoro prostaglandin A2 analogs |
| US3974191A (en) * | 1973-07-20 | 1976-08-10 | The Upjohn Company | 16-Fluoro prostaglandin F1 analogs |
| US3974193A (en) * | 1973-07-20 | 1976-08-10 | The Upjohn Company | 16-Fluoro prostaglandin B2 analogs |
| US4187381A (en) * | 1973-08-06 | 1980-02-05 | Hoffmann-La Roche Inc. | 16-Substituted prostaglandins |
| US4017534A (en) * | 1974-06-03 | 1977-04-12 | American Cyanamid Company | 16-Fluoro-11-deoxy-13-dihydro-prostaglandin |
| US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
| US3969381A (en) * | 1975-02-21 | 1976-07-13 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin B1 analogs |
| US3969380A (en) * | 1975-02-21 | 1976-07-13 | The Upjohn Company | 16-Fluoro prostaglandin F2 analogs |
| US3969379A (en) * | 1975-02-21 | 1976-07-13 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin A1 analogs |
| US3969377A (en) * | 1975-02-21 | 1976-07-13 | The Upjohn Company | 16-Fluoro prostaglandin E1 analogs |
| US4113873A (en) * | 1975-04-26 | 1978-09-12 | Tanabe Seiyaku Co. Ltd. | 8-azaprostanoic acid derivatives |
| US4003911A (en) * | 1975-09-26 | 1977-01-18 | E. I. Du Pont De Nemours And Company | Selected 3-pyrrolidinones and 2,4-pyrrolidindiones |
| US4032533A (en) * | 1976-02-19 | 1977-06-28 | E. I. Du Pont De Nemours And Company | 3,4-disubstituted-1,3,4-thiadiazoline-2,5-diones |
| IL49325A (en) * | 1976-03-31 | 1979-11-30 | Labaz | 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them |
| DE2619638A1 (de) | 1976-05-04 | 1977-11-17 | Hoechst Ag | Pyrrolidone und verfahren zu ihrer herstellung |
| US4177346A (en) * | 1976-08-06 | 1979-12-04 | Pfizer Inc. | 1,5-Disubstituted-2-pyrrolidones |
| US4211876A (en) * | 1979-06-13 | 1980-07-08 | E. I. Du Pont De Nemours And Company | 3-Pyrazolidinone carboxamides |
-
1980
- 1980-08-11 US US06/176,784 patent/US4320136A/en not_active Expired - Lifetime
-
1981
- 1981-08-06 CA CA000383299A patent/CA1161447A/en not_active Expired
- 1981-08-07 DK DK352281A patent/DK352281A/da not_active Application Discontinuation
- 1981-08-10 DE DE8181303641T patent/DE3170838D1/de not_active Expired
- 1981-08-10 AT AT81303641T patent/ATE13667T1/de not_active IP Right Cessation
- 1981-08-10 JP JP56124205A patent/JPS5754166A/ja active Pending
- 1981-08-10 EP EP81303641A patent/EP0046082B1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4320136A (en) | 1982-03-16 |
| JPS5754166A (en) | 1982-03-31 |
| EP0046082A3 (en) | 1982-03-03 |
| CA1161447A (en) | 1984-01-31 |
| EP0046082A2 (de) | 1982-02-17 |
| DK352281A (da) | 1982-02-12 |
| DE3170838D1 (en) | 1985-07-11 |
| EP0046082B1 (de) | 1985-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE13667T1 (de) | 8-aza-16,16-difluor-prostanoide. | |
| ES8600377A1 (es) | Un metodo para preparar una composicion acuosa para limpieza | |
| FI841480L (fi) | Anvaendning av klordioxidgas som ett kemiskt steriliseringsmedel. | |
| LU88359I2 (fr) | Claritine | |
| ES2071169T3 (es) | 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas. | |
| ES8203375A1 (es) | Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras | |
| NL189272C (nl) | Bipolaire transistor. | |
| DE3381898D1 (de) | Prostaglandin enthaltende zusammensetzungen. | |
| FI832884L (fi) | Desoxiuridinderivat, deras framstaellningsfoerfaranden och anvaendning som farmaceutiska medel | |
| NO160325C (no) | Demonterbar stolfot. | |
| FI812539L (fi) | Substituerade enantolaktamderivat som antihypertensiva medel | |
| NO153993C (no) | Baandsag. | |
| FI830739A7 (fi) | Menetelmä mekvitasiinin vasemmalle kiertävän isomeerin valmistamiseksi. | |
| BG40952A3 (en) | Herbicide means | |
| SU1095611A1 (ru) | Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью | |
| BG36931A3 (en) | Method for preparing substituted benzamide | |
| NO812097L (no) | Partikkelformig, saapeholdig vaskemiddelblanding. | |
| FI834588L (fi) | Vattenhaltigt haerdningsmedel foer laettmetallegeringar pao aluminiumbas. | |
| FI832241A7 (fi) | Antihypertensiivisina aineina käyttökelpoiset substituoidut fenyylipiperatsiiniyhdisteet, ja menetelniiden valmistamiseksi. | |
| ES8801647A1 (es) | Un procedimiento para la preparacion de piridazinilimidazolidinonas | |
| IT8322393A0 (it) | Supporto per albero. | |
| SU1269296A1 (ru) | Гербицидный состав | |
| BG42351A3 (bg) | Средство за регулиране растежа на растения | |
| SU1131198A1 (ru) | 2-Этоксикарбонил-3-бромметил-4,4-диметилбутенолид-2, проявляющий противостафилококковую активность | |
| SU1066155A1 (ru) | п-Толилсульфонилгидразиды диарилгликолевых кислот, проявляющие ростстимулирующую активность |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |